of the 24 patients receiving mitoxantrone ( 10 mg/m2/day x 5 ) , one of nine with acute nonlymphoblastic leukemia ( anll ) in relapse , one of five with acute lymphoblastic leukemia in relapse , and one of seven with blastic chronic myelogenous leukemia achieved remission .
C0026259
mitoxantrone
C0023467
acute nonlymphoblastic leukemia